Author

Madeline M. Schuck

Observed names: Madeline Schuck, Schuck, Madeline

Institution: Massachusetts General Hospital

Observed institutions: Brigham and Women's Hospital, Harvard University, MGH Institute of Health Professions, Massachusetts General Hospital

OpenAlex ID: A5113899264

Structure of the Mucosal and Stool Microbiome in Lynch Syndrome

2020 · Yan Yan, David A. Drew, et al. · Cell Host & Microbe · 63

Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial

2020 · David A. Drew, Madeline M. Schuck, et al. · Cancer Prevention Research · 41

ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial

2017 · David A. Drew, Samantha M. Chin, et al. · Trials · 40

Putting it into practice

2019 · Heather Cleveland, Jordyn E. Durkin, et al. · JAAPA · 1

Effect of icosapent ethyl treatment on colorectal tissue marine ω-3 polyunsaturated fatty acid levels among patients with a history of adenoma: a prospective, single-arm clinical trial

2026 · Yufeng Chen, Sunjeong Bae, et al. · American Journal of Clinical Nutrition

Data from Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial

2023 · David A. Drew, Madeline M. Schuck, et al.

Data from Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial

2023 · David A. Drew, Madeline M. Schuck, et al.

Supplementary Materials from Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial

2023 · David A. Drew, Madeline M. Schuck, et al.

Supplementary Materials from Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial

2023 · David A. Drew, Madeline M. Schuck, et al.

389 Aspirin Reduces Pge2 Biosynthesis to Levels Associated With Reduced Risk of Adenoma and Colorectal Cancer: a Double-blind, Placebo-controlled Randomized Trial.

2020 · David A. Drew, Madeline M. Schuck, et al. · Gastroenterology

Sa1992 - Feasibility, Safety, and Initial Efficacy of Cathepsinactivatable Fluorescent Probes for Molecular Detection of Pancreatic Adenocarcinoma Micrometastases

2018 · David A. Drew, Madeline M. Schuck, et al. · Gastroenterology

Tu1963 - Feasibility, Safety, and Initial Efficacy of Cathepsinactivatable Fluorescent Probes for Molecular Detection of Colorectal and Esophageal Neoplasia

2018 · David A. Drew, Dylan C. Zerjav, et al. · Gastroenterology

Additional file 1: of ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial

2017 · Drew, David, Chin, Samantha, et al. · Figshare

Additional file 2: of ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial

2017 · Drew, David, Chin, Samantha, et al. · Figshare

Works count: 17

Citation count: 145

H-index: 3

I10-index: 3